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Abstract
Background: Previous studies have either investigated the relationship of HPV with oral cancer or the prevalence
of HPV on the oral cavity. The purpose of this investigation was to study the prevalence of HPV in oral cavity of
women with oral sex practices and cervical lesions.
Methods: Forty six (46) non-smokers and non-alcoholic patients attended the “Clínica de Displasias” of “Ciudad
Juarez” were sampled. This population had a CIN diagnosis sometime between the previous six months. On
previous consent they filled out a questionnaire related to their oral sex practices. Afterwards one swab from
cheeks and another from palate/gum were taken; PCR was used to determine generic HPV, HPV16 and HPV18.
Results: Seventy two percent (72%) of the patients stated to have oral sex practices regularly which all of them
were positive to HPV either in oral mucus, palate/gum or both. The total of the given results showed that 35% had
HPV16; among those distributed in 26% with regular oral sex practices and 9% stated as never practiced oral sex.
An association was found between oral HPV16 positivity and progression to cervical CIN advanced lesions. On the
other hand HPV18 was not detected. The frequency of HPV16 was higher in buccal mucosa (23%) versus palate/
gum (16%).
Conclusions: This study suggests that buccal HPV16 infection is associated with CIN progression.
Background
Human papillomaviruses (HPVs) are a family of small
(55 nm) icosahedral, non-enveloped virus with a circular
double-stranded DNA genome of 7-8 kbp and with a
special affinity for epithelial cells [1,2]. Over 200 geno-
types of papillomaviruses infect the skin and mucosal
surfaces [2]. The most common oncogenic HPV are
associated with leukoplakia and squamous carcinoma.
While the majority of the HPV types have affinity to
grow on skin, oral lesions, genitals, anal and larynx [1].
Some HPV types are considered as high risk; most nota-
bly 16, 18, 31, 33, 35, 39, 45, 52, and 58 and have been
shown to be a necessary cause for Cervical Cancer
development [3]. Cervical cancer is a major public
health problem around the world; in some developing
countries it is the most frequent female cancer, as well
as the main cause of cancer related death among
women [4,5].
The potentially oncogenic HPVs has been associated
with oral squamous cell carcinoma [6,7]. Some evidence
has linked them to orogenital contact with the transmis-
sion of papillomavirus from the genital zone to the oral
cavity [8]. It is suggested that oral HPV infection fre-
quency is different from cervical infection and associated
with age [9]. Other studies have detected the presence
of HPV in the epithelium of the oropharynx in women
with genital HPV by using a cytological examination
and the Papanicolaou technique [10]. These studies alert
the possibility of a natural reservoir of HPV at a locus
outside of the genital region, which could serve as a
reinfection focus [10]. Additionally the HPV is rarely
present in the vagina of virgin women even with the use
of tampons or digital penetration [11].
Despite the recognition of a HPV-associated oral
malignancy, it is unclear to what extent cervical HPV
infection is translocated to oral HPV infection. Previous
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cervical infection is associated with sexual behavior and
immunosuppressant [12,13]. The majority of the studies
of buccal HPVs made in the past have explored the rela-
tionship between HPV and the development of oral can-
cer; these studies detected HPV in DNA extracted from
the oral cavity of patients with oral lesions and/or
abnormalities [14-18] shown that HPVs that infect the
genital area can also infect the oral cavity [19]. In
healthy Japanese; HPV in oral cavity was present in 0.6%
of the population [20]. Other studies have proposed that
mothers may serve as the source of infant HPV infec-
tion which suggested the possibility of a non-sexual
transmission of the virus [21]. In the few studies in
which oral and anogenital HPV infections were ana-
lyzed, oral HPV infection frequency appeared to be
lower than anogenital infection [16,17,22,23]. However,
oral and cervical HPV prevalence were similar in a
small group with high prevalence of oral or anogenital
condylomata [16]. These studies were performed in a
high risk population therefore the relationship between
HPV infection in cervix and oral cavity related to oral
sex practices remains unexplored. The aim of this study
was to determine the frequency of HPV in the oral cav-
ity of a Mexican women population with histopathologi-
cal diagnosis of cervical lesions and to describe the viral
infection in relation to oral sex practices and habits to
share personal objects such as toothbrush.
Results
This study included 46 voluntary non-smoker and non-
alcoholic women that attend to the “C l í n i c ad eD i s p l a -
sias del Sector Salud” in the City of Juarez, México. The
female subjects attend to this clinic because they pre-
sented previous CIN alterations. After they filled out the
inform consent and the questionnaire; the patients were
instructed by imitation for autosampling the oral cavity.
Once in the laboratory and after DNA extraction the
human b-globin gene was amplified as an internal con-
trol of human DNA as well as a DNA with quality for
PCR. Those cases that failed in the b-globin gene ampli-
fication were excluded rather than those samples tested
positive for b-globin were further used for generic HPV
that amplify a wide range of HPV types. After generic
HPV positivity the specific PCR for HPV16 and HPV18
were performed. Two regions were sampled in the oral
cavity; the first one was the buccal mucosa and the sec-
ond one was the palate and gum altogether (P/G). All
women studied carried generic HPV either in mucosa or
P/G, this gives a frequency of 100% for the buccal cav-
ity. However, if the mucosa and P/G are considered
separately (Table 1) the percentages of HPV infection
were as follows: for generic HPV in the buccal mucosa
was 86%, and for P/G was 88% and for HPV16 23% for
mucosa and 16% for P/G. The higher frequency of
HPV16 in woman having oral sex would suggest a
higher risk, however number are too small to see any
significant risk.
Sixty-three percent (63%) of the studied female sub-
jects were married, 19% were in common law marriage
and 7% were singles. The mean age was 35 years old
ranging between 19 to 63 years old (not shown in
tables). Table 2 shows the results of the applied ques-
tionnaire. Generic HPV was detected in all cases either
in palate-gum, buccal mucosa, or both. However,
HPV16 was detected in 35% of all patients and 73% of
the patients stated to practice oral sex frequently. The
association between the presence of HPV16 and the
frequently practice of oral sex was not observed. From
the total women, 53% had oral sex mutually (fellatio
and cunnilingus, Table 2). This group had the highest
frequency of HPV16 (53%) among those patients stated
to practice oral sex. Interestingly the only three
women that practice fellatio but did not received cun-
nilingus (7%) were generic HPV positive but HPV16
negative.
All women were CIN diagnosed along the previous six
months (according to Bethesda classification) because of
that; it is clearly evident the association between oral
HPV16 positivity and CIN progression 51% (Mann
Whitney U test, p = 0.023), followed by 28% with
inflammatory alterations; and finally 21% did not present
cervical alterations (Table 2). Two women that evolved
positively to the treatment at that time of gynecological
visit were observed. They had no cervical alterations but
were HPV16 positive.
The majority of the patients stated not to use con-
doms while practicing oral sex, and 60% of them were
buccal HPV16 positive. Apparently the use of condoms
during oral sex would prevent infection of the oral
mucosa (Table 2).
T h eb i g g e s tg r o u po fp a t i e n t s( 4 7 % )d e c l a r e dt oh a v e
only one sex partner, 23% had two partners and 2% had
more than two partners (Table 2).
Table 1 Frequency of HPV by buccal region and its
relation with oral sex practices
Overall (N = 43) Oral sex Generic HPV HPV16
Buccal mucosa n (%) n (%)
No 11 26 3 7
Yes 26 60 7 16
Total 37 86 10 23
Palate/gum n (%) n (%)
No 9 21 2
Yes 29 67 6 14
Total 38 88 7 16
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spoons, toothbrush or candies (Table 2). But an impor-
tant fraction (40%) recognized to share those objects
occasionally (Table 2).
Discussion
The prevalence rate of HPV in normal oral mucosa has
been reported to vary greatly because of differences in
types of samples, collection, detection methods, level of
sensitivity, PCR primers used, and PCR inhibitors
[10,15,22-32]. A previous study showed a high preva-
lence of oral HPV infection (81%) among healthy people
in Japan [20].
In this study, we performed the HPV detection by PCR
using the MY09/MY11 primer pair; which, it is widely
used on epidemiological studies and showed to be equally
sensitive than confirmatory nested PCR with GP5+/GP6+
primers, with a correlation of 94% [33-35]. Generic HPV
in our sampled population had a frequency of 100%.
These women that attend to the “Clinica de Displasias de
Ciudad Juárez” can be considered as high risk population
since they came to this clinic attending some cervical
abnormality. It is notably interesting that all these
women were positive and taking into account that they
had some cervical problem; this number became compar-
able to the 81% found in oral cavity of healthy Japanese
and the 90% buccal HPV among positive genital HPV in
Brazilian women [7,20]. Buccal presence of HPV16 in
our study was 35% (Table 2). However, we have observed
differences by the anatomic region of the oral cavity
sampled that was 23% for buccal mucosa to 16% on P/G.
To sum up, this HPV point prevalence was higher than
those of other normal oral HPV studies as well as in high
risk population [20,26,30]. The reasons of such a high
HPV prevalence in the normal oral cavity in women of
the City of Juarez are not yet explored. Further studies
are needed to clarify this as well as the differences in
HPV infection at each normal oral site and the use of
Table 2 Buccal HPV16 associated to oral sex practices
Overall (N = 43) HPV16 negative (N = 28) HPV16 positive (N = 15)
n% n % n %
Oral Sex frequency
Never 12 28 8 29 4 27
Frequently 31 72 20 71 11 73
Oral Sex type
Do not practice 1 2 1 4 0 0
To her partner 3 7 3 11 0 0
Both 23 53 15 54 8 53
Did not answer 16 37 9 32 7 47
*Histological biopsy results
Without alterations 9 21 7 25 2 13
Inflammatory Alterations 12 28 9 32 3 20
CIN-I & CIN-II 22 51 12 43 10 67
Use of condom while practicing oral sex
Do not practice oral sex 12 28 8 29 4 27
Use of Condom 1 2 1 4 0 0
Do not use Condom 25 58 16 57 9 60
Did not answer 5 12 3 11 2 13
Number of Partners to whom practice oral sex
Do not practice oral sex 1 2 1 4 0 0
One 20 47 12 43 8 53
Two 10 23 7 25 3 20
More than two 1 2 1 4 0 0
Did not answer 11 26 7 25 4 27
Personal objects sharing
Do not practice 23 53 17 61 6 40
Occasionally 17 40 9 32 8 53
Frequently 2 5 1 4 1 7
Did not answer 1 2 1 4 0 0
* Mann Whitney U = 1.9819 p = 0.0237 [42]; http://department.obg.cuhk.edu.hk/researchsupport/MannWhitney.ASP).
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to prevent infections of the oral mucosa.
We evaluated HPVs only in buccal samples. Although
in cancers of the upper aerodigestive tract HPV has
been detected predominantly in the oropharynx and
tonsil [29,35]. A risk factor for the occurrence of HPV-
infected oral and for presence of HPV in the normal
cervix is an increase in the number of sexual partners
[10,20,28], but in our study the number of sex partners
did not seem to increase the risk of HPV-16 oral infec-
tion. Oral sex practices may affect oral and cervical sites
similarly. Local factors that have been found to influence
the persistence of HPV at the cervix may affect the nat-
ural history of oral HPV infections. These factors
include coinfection by Chlamydia trachomatis [30,31] or
herpes simplex virus [32], smoking [36], age [37], HPV
type [38], and the use of hormones and contraceptives
[23,36,39]. However, all these reports did not implement
any questionnaire to identify any factors behind the
transmission of HPVs. We have collected information
about sexual behavior of the patients, to examine the
relationship between cunnilingus and incidence of
mouth HPV infection.
In our study HPV16 in mouth was significantly asso-
ciated with genital CIN progression (Mann Whitney U
test, p = 0.023), suggesting that women with HPV16
persistent infections and progression to advanced genital
lesions have higher risk of HPV16 detection in the oral
mucosa. We found HPV16 infection in a media of 37
years. As this type of HPV is related to cancer; it is also
considered as high-risk mucosal type virus [40] and this
p h e n o m e n as h o u l db ek n o w nb yt h ed e n t i s t sa n d
pathologists.
The role of men as possible vectors of HPV has been
discussed previously [41]. Our results suggest that trans-
mission of HPV occurs not only via sexual contact but
also through oral contact. The fact that women that stated
not to receive cunnilingus were HPV16 free; this probably
reflects that their partner is not translocating the virus
from the women genitals to the mouth but probably the
autoinoculation is more frequent that we think.
In a cross-sectional study of Fahkyr [23], oral HPV
infection was found to be less prevalent than cervical
HPV infection in both HIV-positive and -negative
women. Oral HPV infections were detected in approxi-
mately 25% of HIV-positive women and 9% of HIV-
negative women. Our results showed a much higher
prevalence in oral cavity of women with or without cer-
vical lesions then the study of Fahkyr [23]. These data
s u g g e s tt h a tt h eo r a lc a v i t ym a yb ear e s e r v o i ro fH P V
infection with a sufficiently high prevalence to affect the
dynamics of HPV transmission between the populations.
Several aspects for the relationship among cervical- and
oral-HPV remain poorly described. A prospective study
to clarify the interrelationship between HPV infections
at both sites and to understand possible differences in
incidence and factors affecting clearance or persistence
in the oral cavity and the cervix is warranted. These
include differences by anatomic site in HPV prevalence
and HPV type distribution. Also unknown are the pre-
valence of single and multiple oral or cervical infections
and whether multiple infections are type concordant.
Our data hint, it is that oral cavity should be consid-
ered as a potential reservoir for HPV and may not be
entirely independent of the cervical reservoir as well as
the partner genitalia. In this study we did not sample
the partner’s genitalia but we assume that both genitalia
are infected since these are considered as sexually trans-
missible infections. Thus the presence of the virus in
the oral cavity should be explained not only by oral con-
tact with genitalia but also by autoinoculation. We are
aware about the different prevalence data in oral HPV
DNA detection ought to different populations and
methodologies. Consequently comparative studies will
be required in parallel studies of the relationship
between incident squamous epithelial lesions and persis-
tence oral HPV. This will help to understand the invol-
vement of HPV in the development of oral cancer as
well as the role of oral cavity in the cervical infection.
Conclusions
In conclusion, this study suggests that women with gen-
ital HPV infection have also some kind of HPV infecting
their oral cavity and HPV16 detection in the mouth is
associated to HPV16 persistence in the genital tract and
CIN progression.
Methods
Patients and sampling
This study was performed on summer 2008. All women
had a previous CIN diagnosis between six months pre-
vious to the study. The Inclusion criteria were any
women that attend to “Clínica de Displasias” for any
cervical associated problem, no matter their origin or
place of living (Mexico or USA), sign an informed con-
sent and fill a questionnaire about their sex habits. The
exclusion criteria were: smoking and alcoholism habits.
All women studied were above eighteen years old. The
full protocol was approved by the Ethics Committee of
the Universidad Autonoma de Ciudad Juarez and the
Clinica de Displasias. Women were asked to autosam-
pling with a cotton swab the two cheeks and with other
cotton swab the palate/gum (P/G). In both cases tissues
were rubbed for a minute. Cotton swabs were immersed
into 15 mL tube containing 1 mL of transporting media
(10 mM Trizma, pH 8.8; 1 mM EDTA; 0.01% Sodium
azide; 50 μg/mL Ampicillin; 1 μg/mL Proteinase K) and
stored at -20°C in between 24 h after collection.
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Samples were unfreeze, centrifuged at 3,500 rpm in a
clinical centrifuge, cotton swab removed and the trans-
porting media was transferred to a 2 mL microtube that
was centrifuged 5 min at 3,500 rpm at 4°C. 300 μLo f
clear supernatant were taken into a new tube and 25 μL
of 5 M sodium acetate and 1 mL of isopropanol were
added consecutively and centrifuged at 14,000 rpm at 4°
C for 5 min. Pellet were washed with 1 mL of 70% etha-
nol and dried overnight at room temperature. Pellet was
dissolved with 100 μL rehydration solution (Promega
A7963) and incubated at 65°C for 20 min.
PCRs for generic HPVs were assembled with 5 μL
DNA, 12.5 μL 2X GoTaq Green Master Mix (Promega).
5 μL MY11/MY09 primer mix at 2.5 μM each, and
2.5 μL water. PCR conditions were 40 cycles at 94°C for
60 s, 55°C for 60 s, 72°C for 60 s, with an initial denatura-
tion at 94°C for 5 min and a final extension of 72°C for 7
min [33]. PCR products were examined in 2% agarose
gels using base pairs standard (Promega G7521). PC04
and GH20 primers for human betha-globin gene were
used as internal controls. For HPV16 and HPV18 specific
primers were used as described elsewhere [34,35].
Statistical analysis
Questionnaire answers, previous histopathological
results and buccal HPVs results were analyzed with
SPSS statistical software version 11 and Mann Whitney
U Test [42].
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